Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Morning plasma concentrations of
beta-endorphin
immunoreactivity were significantly higher in a group of depressed patients meeting the Research Diagnostic Criteria for Major
Depressive disorder
or Schizo-affective disorder, depressed, than in age- and sex-matched groups of normal controls and psychiatric patients without affective disorders. Furthermore, physostigmine-stimulated release of
beta-endorphin
immunoreactivity was also significantly greater in the depressed patients. These results provide the first evidence for elevated plasma concentrations of
beta-endorphin
in depression and also represent further evidence for cholinergic supersensitivity in depression. These results suggest that elevated plasma concentrations of
beta-endorphin
and cholinergically stimulated hypothalamic-pituitary
beta-endorphin
release, might potentially represent biological state or trait markers for depression.
...
PMID:beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms. 629 94
Depressive disorders
are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large body of preclinical and clinical evidence points to a key role of the
corticotropin
-releasing hormone (CRH) receptor 1 subtype (CRHR1) in mediating CRH-elicited effects in anxiety, depressive disorders and stress-associated pathologies. Genetic modification of CRHR1 function in mice by the use of conventional and conditional knockout strategies enables further analysis of specific elements in the CRH circuitry. The recent characterisation of several selective small-molecule CRHR1 antagonists offers new possibilities for the treatment of anxiety and depression.
...
PMID:Getting closer to affective disorders: the role of CRH receptor systems. 1531 Apr 62